Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline CFR Q1 2026 Earnings Earnings Beat Driven by Strong Core Performance CCIF Q1 2026 Earnings Net Investment Income Misses Estimates Despite Small Stock Gain EXPE Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction Orion SA OEC Q1 2026 Earnings A Miss on EPS Weighs on Performance but Shares Rally CV Q1 2026 Earnings EPS Misses Estimates as Company Reports Wider Loss